1.3.1.74: 2-alkenal reductase [NAD(P)+]
This is an abbreviated version!
For detailed information about 2-alkenal reductase [NAD(P)+], go to the full flat file.
Word Map on EC 1.3.1.74
-
1.3.1.74
-
quercitrin
-
alpha,beta-unsaturated
-
dicumarol
-
2-alkenals
-
15-ketoprostaglandins
-
13-reductase
-
dihydrochalcone
-
acylfulvenes
- 1.3.1.74
- quercitrin
-
alpha,beta-unsaturated
- dicumarol
-
2-alkenals
-
15-ketoprostaglandins
-
13-reductase
- dihydrochalcone
- acylfulvenes
Reaction
Synonyms
2-alkenal reductase, 2AER, AER, alkenal/one oxidoreductase, alkenal/one reductase, AOR, At-AER, At5g16970, AtAER, AtAOR, bifunctional LTB4 12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase, CS-670 double-bond reductase, CsAOR, Dbr1, double bond reductase, LTB4 12-HD/PGR, NADPH alkenal/one oxidoreductase, NADPH-dependent 2-alkenal reductase, NADPH-dependent alkenal/one oxidoreductase, ZmAER
ECTree
Advanced search results
Disease
Disease on EC 1.3.1.74 - 2-alkenal reductase [NAD(P)+]
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Neoplasms
Increased expression of prostaglandin reductase 1 in hepatocellular carcinomas from clinical cases and experimental tumors in rats.
Neoplasms
NADPH alkenal/one oxidoreductase activity determines sensitivity of cancer cells to the chemotherapeutic alkylating agent irofulven.
Neoplasms
Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase.
html completed